Researchers described the efficacy of tofacitinib in reducing pain in patients with inflammatory rheumatic and musculoskeletal diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Patients with osteoarthritis and diabetes experience greater knee pain and worse physical and mental status compared with patients without diabetes.
The FDA Advil Dual Action with Acetaminophen for the temporary relief of minor aches and pains due to arthritis and more.
The threshold for pain interfering with daily activities was reported to be 3 on a 0 to 10 numeric rating scale by patients with rheumatoid arthritis.
The FDA has accepted for review the Biologics License Application for tanezumab 2.5mg administered subcutaneously for moderate to severe osteoarthritis pain.
The over-the-counter (OTC), drug-free medical device, ActiPatch®, has obtained a new 510(k) clearance from the Food and Drug Administration (FDA) for the adjunctive treatment of musculoskeletal pain.
Investigators assessed sex differences in interleukin-6 response after exposure to acute pain among patients with knee osteoarthritis who were scheduled for total knee arthroplasty.
Researchers assessed and compared the effectiveness of neurodynamic mobilization techniques with passive robotic physiologic movement for patients with hand osteoarthritis.
Data from a study investigating the efficacy and safety of 6-week low-dose prednisolone in patients with painful hand osteoarthritis were presented at the 2019 ACR Annual Meeting.
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
